RhoH

From WikiMD's WELLNESSPEDIA

RhoH is a small GTPase belonging to the Rho family of proteins, which play a critical role in regulating various cellular processes such as cell morphology, cell migration, cell cycle progression, and gene expression. Unlike most members of the Rho family, RhoH is unique in that it is predominantly expressed in hematopoietic cells, including both myeloid and lymphoid lineages, and is involved in controlling the immune system's function.

Function[edit]

RhoH acts as a regulatory molecule within cells, modulating the actin cytoskeleton to influence cell shape and movement. It is also involved in T-cell receptor (TCR) signaling, playing a crucial role in T-cell development and activation. RhoH's unique feature is its inability to hydrolyze GTP, which means it remains constitutively active once expressed. This characteristic allows it to act as a modulator of signaling pathways rather than a direct signal transducer.

Gene and Expression[edit]

The gene encoding RhoH is located on chromosome 4 in humans. Its expression is tightly regulated, with high levels observed in hematopoietic tissues. Aberrant expression of RhoH has been implicated in various hematological malignancies, including leukemia and lymphoma, suggesting its role in the development and progression of these cancers.

Clinical Significance[edit]

Alterations in RhoH expression or function have been associated with several diseases, particularly those affecting the hematopoietic system. Overexpression or underexpression of RhoH can disrupt normal cellular processes, leading to the development of malignancies. Furthermore, mutations in the RhoH gene have been identified in certain types of cancer, highlighting its potential as a target for therapeutic intervention.

Research[edit]

Ongoing research is focused on elucidating the precise mechanisms by which RhoH functions within cells and its interactions with other proteins. Understanding the role of RhoH in disease pathogenesis, particularly in hematological malignancies, could lead to the development of novel therapeutic strategies targeting this protein.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.